Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat’s FREE daily newsletter. Short interest in Johnson & Johnson has recently increased by 9.97%, indicating that investor sentiment is decreasing significantly. Upgrade to MarketBeat Daily Premium to add more Johnson & Johnson stock forecast stocks to your watchlist. Credit Suisse to hold a conference 31st Annual Healthcare Conference to be held in Rancho Palos Verdes, CA on November 7-10. Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
TipRanks is a comprehensive investing tool that allows private investors and day traders to see the measured performance of anyone who provides financial advice. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. Shares of Abiomed Inc. rocketed 48.8% toward a 14-month high in premarket trading Tuesday, after the provider of medical technology that supports circulation and oxygenation agreed to acquired by Johnson & Johnson in a d… If a user or application submits more than 10 requests per second, further requests from the IP address may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website. He’s also written for Esquire magazine’s Dubious Achievements Awards.
Dividend Stocks to Hold Forever
This service is geared toward helping you collect the safest dividend income in the market. It all starts with Brad’s “SWAN” portfolio, of the 10 best companies to own through any market. Four Healthcare Stocks To Watch This Week Healthcare has long been a wise investment, as the industry consistently grows yearly. The company’s average rating score is 2.36, and is based on 4 buy ratings, Forex news 7 hold ratings, and no sell ratings. Johnson & Johnson released its earnings results on Oct 18, 2022. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.477 by $0.073. The company reported upbeat Q2 results last month, but it lowered its full-year outlook owing to the impact of foreign exchange, and this didn’t sit well with the investors.
Johnson & Johnson is the latest in a line of mega-cap household names that have split their businesses in a bid to boost growth. JNJ stock was down roughly 1% when markets opened this morning. That’s despite earnings https://dotbig.com/markets/stocks/JNJ/ per share and revenue beating estimates. Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.
Johnson & Johnson JNJ:NYSE
68.59% of the stock of Johnson & Johnson is held by institutions. High institutional ownership can be a signal of strong market trust in this company. In the past three months, Johnson & Johnson insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $36,791,022.00 in company stock. MarketBeat has tracked 13 news articles for Johnson & Johnson this week, compared to 22 articles on an average week. Johnson & Johnson pays a meaningful dividend of 2.55%, higher than the bottom 25% of all stocks that pay dividends. Johnson & Johnson has a short interest ratio (“days to cover”) of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
- Data, information, or opinions contained in Quantalytics in any form give no consideration to any particular individuals’ investment needs or objectives, nor do they consider any individuals’ financial condition.
- Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey.
- F-RATED STOCKS are those stocks our quantitative multi-factor models score as most probable to fall in price.
- The price of Johnson & Johnson stock has seen a rise of 5% in a month, while it’s up 4% YTD.
- Johnson & Johnson is incorporated in the state of New Jersey.
- As for General Electric, which announced its own separation just a day before the JNJ news, sure, it ain’t what it used to be.
This optimism can be attributed to a court ruling that supported the company’s plans to use the “Texas two-step” strategy. Under this, J&J will declare bankruptcy for its subsidiary that holds its talc… But making https://dotbig.com/ Johnson & Johnson an even more interesting and timely stock to look at, is the fact that in trading on Thursday, shares of JNJ entered into oversold territory, changing hands as low as $167.41 per share.
Ligand Pharmaceuticals Partner Janssen Biotech Gets FDA Approval for Tecvayli
EVP of Johnson & Johnson Makes $13.60M Sale
It’s an iconic dividend stock, and was an original member of the Dow, dating back to 1896. True, GE was dropped from the Dow in 2018, but it has retained at least some of its blue-chip luster. In fact, there’s no shortage of Dow stocks, former Dow stocks, S&P 500 Dividend Aristocrats and other dividend stalwarts that are trying to achieve addition by division.
Subscribe to Kiplinger’s Personal Finance
Profit and prosper with the best of Kiplinger’s expert advice on investing, taxes, retirement, personal finance and more – straight to your e-mail. Buy-and-hold dividend investors may dotbig be forgiven if they feel like they’re having déjà vu all over again. After all, if it seems like many of our most iconic blue-chip dividend payers are getting smaller by the day …
Internet Security Policy
This makes Johnson & Johnson the world’s 10th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company’s outstanding shares and is commonly used to measure how much a company is worth. Q.ai is the trade name of Quantalytics Holdings, LLC. Q.ai, LLC is a wholly owned subsidiary of Quantalytics Holdings, LLC (“Quantalytics”). https://www.forextime.com/education/forex-trading-for-beginners Quantalytics is not a registered investment adviser, brokerage firm, or investment company. Any data, information, or opinions presented by Quantalytics are for general information purposes only. Such data, information, or opinions are not an offer to sell or to buy, or a solicitation to buy or sell any securities. Any forward looking estimates presented by Quantalytics may prove to be incorrect and not be realized.
The largest positive contribution comes from its “Physical diseases” impact, which is mostly driven by its “Ustekinumab”, “Clinical research services for physical health”, “Rivaroxaban”, “Daratumumab”, “Ibrutinib”, and “HIV medication” products. The Johnson & Johnson 52-week low stock price is 155.72, which is 12.1% below the current share price. The Johnson & Johnson 52-week high stock price is 186.69, which is 5.3% above the current share price. MeiraGTx announces $25M investment from Johnson & Johnson Innovation On November 9, 2022, JJDC purchased $25 million of MeiraGTx’s ordinary shares in a private placement. The price of dotbig has seen a rise of 5% in a month, while it’s up 4% YTD.